Skip to main content
Equibles
TCRX logo

TCRX · TScan Therapeutics, Inc. · Webcasts, Transcripts & Audio

Track TCRX — free

Use TCRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TCRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.22 +0.01 (+6.57%) At close · Oct 20
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“However, substantial doubt about the Company's ability to continue as a going concern exists. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Therefore, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”
View the 10-Q filed Aug 12, 2026
Market Cap
$14.25M
Shares
67.78M
Volume · Oct 20 559.56K Avg daily vol (3M) 763.51K

TScan Therapeutics, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for TScan Therapeutics, Inc. (TCRX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Key facts CIK 1783328 CUSIP 89854M101 13F (30d) 1 filings 1 filers Visit website Investor relations